Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation

Merkely, Béla and Hatala, Robert and Merkel, Eperke Dóra and Szigeti, Mátyás and Veres, Boglárka and Fábián, Alexandra and Osztheimer, István and Gellér, László and Sasov, Michal and Wranicz, Jerzy K and Földesi, Csaba and Duray, Gábor and Solomon, Scott D and Kutyifa, Valentina and Kovács, Attila and Kosztin, Annamária (2024) Benefits of upgrading right ventricular to biventricular pacing in heart failure patients with atrial fibrillation. EUROPACE, 26 (7). No. euae179. ISSN 1099-5129

Preview	Text euae179.pdf - Published Version Available under License Creative Commons Attribution. Download (303kB) | Preview
Preview	Text (graphical abstract) graphical_abstract_europace.jpeg - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Aims: Recommendations on cardiac resynchronization therapy (CRT) in patients with atrial fibrillation or flutter (AF) are based on less robust evidence than those in sinus rhythm (SR). We aimed to assess the efficacy of CRT upgrade in the BUDAPEST-CRT Upgrade trial population by their baseline rhythm. Methods and results: Heart failure patients with reduced ejection fraction (HFrEF) and previously implanted pacemaker (PM) or implantable cardioverter defibrillator (ICD) and ≥20% right ventricular (RV) pacing burden were randomized to CRT with defibrillator (CRT-D) upgrade (n = 215) or ICD (n = 145). Primary [HF hospitalization (HFH), all-cause mortality, or <15% reduction of left ventricular end-systolic volume] and secondary outcomes were investigated. At enrolment, 131 (36%) patients had AF, who had an increased risk for HFH as compared with those with SR [adjusted hazard ratio (aHR) 2.99; 95% confidence interval (CI) 1.26–7.13; P = 0.013]. The effect of CRT-D upgrade was similar in patients with AF as in those with SR [AF adjusted odds ratio (aOR) 0.06; 95% CI 0.02–0.17; P < 0.001; SR aOR 0.13; 95% CI 0.07–0.27; P < 0.001; interaction P = 0.29] during the mean follow-up time of 12.4 months. Also, it decreased the risk of HFH or all-cause mortality (aHR 0.33; 95% CI 0.16–0.70; P = 0.003; interaction P = 0.17) and improved the echocardiographic response (left ventricular end-diastolic volume difference −49.21 mL; 95% CI −69.10 to −29.32; P < 0.001; interaction P = 0.21). Conclusion: In HFrEF patients with AF and PM/ICD with high RV pacing burden, CRT-D upgrade decreased the risk of HFH and improved reverse remodelling when compared with ICD, similar to that seen in patients in SR.

Actions (login required)

Edit Item